The Mounjaro label gives tirzepatide an elimination half-life of approximately 5 days, and the Zepbound label approximately 5 to 6 days.[1][2] Both labels say steady-state levels were reached after 4 weeks of once-weekly dosing, and put the peak 8 to 72 hours after an injection.

These figures come from section 12.3 (Pharmacokinetics) of each prescribing information, read on DailyMed on 20 November 2026. They are study averages, not anyone’s personal numbers, and they are not a guide to timing or skipping doses.

What the labels report

FigureMounjaro labelZepbound label
Elimination half-lifeApproximately 5 daysApproximately 5–6 days
Time to maximum concentration8 to 72 hoursMedian 24 hours (range 8 to 72 hours)
Time to steady stateAfter 4 weeks of once-weekly dosingAfter 4 weeks of once-weekly dosing
Absolute bioavailability (injection)80%80%

The Mounjaro label puts it this way: “The apparent population mean clearance of tirzepatide is 0.061 L/h with an elimination half-life of approximately 5 days, enabling once-weekly dosing.”[1] The Zepbound label says “The elimination half-life is approximately 5-6 days in patients with overweight or obesity, and in patients with OSA and obesity.”[2] Each label states the figure for the patients it describes.

Neither label gives a number of weeks that tirzepatide stays in the circulation after the last dose, so this page does not give one either.

What a half-life means

A half-life is the time it takes for an amount to fall by half. After one half-life, half is left. After two, a quarter. After five, about 3%. The chart shows that halving for a single amount, with one half-life drawn as 5 days, the Mounjaro label’s figure. With 6 days, each step would sit one day later.

Illustration: a single amount halving every 5 daysAn illustration of halving: 100% at the start, then 50, 25, 12.5, 6.25, 3.1 and 1.6% after each further half-life. It is not a prediction of anyone’s levels.0%50%100%100%050%525%1012.5%156.25%203.1%251.6%30Days after a single dose (one half-life = 5 days)
Illustration only: what “half-life” means, drawn as a single amount halving at a fixed rate. It ignores absorption, repeated doses and differences between people, so it is not a prediction of anyone’s levels and not a guide to timing, delaying or skipping doses.

The same numbers as a table:

Half-lives passedDays (at 5 days each)Days (at 6 days each)Share of the starting amount
000100%
15650%
2101225%
3151812.5%
420246.25%
525303.1%
630361.6%

This is plain halving, nothing more. It leaves out absorption (the labels put the peak 8 to 72 hours after an injection, not at the moment of the dose), the effect of one weekly dose landing on top of the last, and differences between people. So it cannot tell you what level anyone has on a given day.

Steady state

Both labels say: “Steady-state plasma tirzepatide concentrations were achieved following 4 weeks of once weekly administration.”[1][2] Steady state is the point where, with a dose every week, the level follows the same pattern from one week to the next. The Mounjaro label links the half-life to the weekly schedule in the words quoted above; this page adds nothing to that.

What the half-life is not

  • It is not a missed-dose rule. Both labels give their own: take a missed dose “as soon as possible within 4 days (96 hours)”, and if more than 4 days have passed, skip it and take the next dose on the regularly scheduled day. The weekly day can be changed if doses are at least 3 days (72 hours) apart.[1][2]
  • It is not a reason to stretch or shorten the interval, or to stop and restart. Those are the prescriber’s decisions.
  • It is not a reading of your own levels. Nothing on this page can tell you that.

For the rest of the label facts, see the Mounjaro and Zepbound label pages and Mounjaro vs Zepbound. For tirzepatide next to semaglutide, see semaglutide vs tirzepatide and semaglutide half-life. The tirzepatide calculator covers vial arithmetic.

A dose on the same day each week is what the label schedule assumes. Kept, the iPhone app this site belongs to, sends the reminder and logs the dose in one tap.

Last checked against the labels: 20 November 2026.

Mounjaro and Zepbound are registered trademarks of Eli Lilly and Company. Kept is independent and not affiliated with, endorsed by or sponsored by Eli Lilly and Company.